about
Angiotensin I converting enzymeUrotensin 2 receptorRho associated coiled-coil containing protein kinase 1Natriuretic peptide receptor 1Adenylate cyclase 6Gap junction protein alpha 5Angiotensin II receptor type 2Purinergic receptor P2Y1Urotensin 2BPurinergic receptor P2Y2Rho associated coiled-coil containing protein kinase 2Potassium large conductance calcium-activated channel, subfamily M, alpha member 1Adenylate cyclase 6Endothelin converting enzyme 1Gap junction protein, alpha 5Angiotensin II receptor, type 2Rho-associated coiled-coil containing protein kinase 1Rho-associated coiled-coil containing protein kinase 2Purinergic receptor P2Y, G-protein coupled 2Purinergic receptor P2Y, G-protein coupled 1Urotensin 2BUrotensin 2Angiotensin II receptor type 1Purinergic receptor P2Y1Angiotensin II receptor, type 2Gap junction protein, alpha 5Urotensin 2Purinergic receptor P2Y2Urotensin 2BPotassium calcium-activated channel subfamily M alpha 1Urotensin 2 receptorAdrenoceptor beta 2Adrenoceptor beta 2Angiotensin II receptor, type 2Urotensin 2 domain containingUrotensin 2, alphaPurinergic receptor P2Y2, tandem duplicate 1Urotensin II-related peptideUrotensin-2 receptor 5Urotensin 2, beta
P682
Cloning, expression, and characterization of a gene encoding the human angiotensin II type 1A receptorAssociation of polymorphism in glutamate-cysteine ligase catalytic subunit gene with coronary vasomotor dysfunction and myocardial infarctionA dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykininLocalization of the human B-type natriuretic peptide precursor (NPPB) gene to chromosome 1p36Polymorphism in glutamate-cysteine ligase modifier subunit gene is associated with impairment of nitric oxide-mediated coronary vasomotor function
P921
Q128861-0A9F0122-787C-4742-98E3-6D3C755298C5Q15319968-B6D73502-E7EA-4FC4-AC01-48C6B0F4CBD4Q21100658-E1BB3146-D7C9-4AA3-B6B9-FE1B68BBC829Q21105144-D98754D2-CDDE-4905-9277-CA476B93D30FQ21111191-724E1119-2E5C-4E28-9DB5-23F1259DCF13Q21113152-5BA1EF52-788A-4BC8-BE9D-F2070363E896Q21113831-A462A41D-B7B9-48DD-BBED-9D0962A82318Q21119575-9C825364-0322-4FBC-ABDD-5CACF4CDED32Q21126717-8E406DBA-FB63-40E5-B132-C39EC3F12614Q21126777-E19FBBE1-B985-45B5-906B-E499701AB762Q21127094-42B9890D-676A-4200-B105-8249220291E8Q21491057-CC0BDFD0-9120-492B-97FD-4AF0C72325A2Q21495342-331F4741-14A3-4D55-880D-263C62E482B1Q21497547-7A2D6095-C37E-45CE-85F4-D60D41A4A56CQ21981041-33A21D4B-5E9B-4EE1-BE45-CA0E53CE396BQ21983453-FE4521EF-8237-4B45-90F4-167A61F9E186Q21987991-4F16DF0F-275D-4EF6-972D-6087A4BA48FAQ21988014-0DA2AA9E-5DD7-4947-A8C4-078F75148BD7Q21990414-7BBF4767-37A4-4ED8-A4B3-D082C9574BA7Q21990415-EC5CD72F-AC11-4A69-A5A2-FA2D102299CAQ21991971-4D2C7A26-02C7-4A46-AE1D-149085D4B0A0Q21991975-E94B22DA-E614-4CEF-9D5F-AC07191776F6Q2819188-A42BB531-D3C4-48EE-A2D4-3A54EBF10AD8Q28557130-1ECE49A7-D0EC-4499-A8F2-3036861E5FF4Q28560159-50EFFB57-5590-4B98-AC5D-297400FC25CFQ28561059-05E07A1C-0BC6-4D31-92DC-502D94665C19Q28561171-E8F77BC3-7F9B-4080-A63B-A63DEBF44EB1Q28562258-C4C94360-3DC2-43A2-9D29-95D13E96DE02Q28562462-802A0B89-AEB9-4EA0-904F-DB683C7EB387Q28562494-D7AA6329-3ACA-4718-A246-29296B485566Q28562806-F9E67BD2-BCEA-4E5F-8EE8-BFBF63B6A61CQ287961-3E884B40-806E-45B8-A8A2-4AD6D3C77D58Q29524327-7128513E-8296-4516-AB52-5C364AEA0734Q29821709-420A6D4C-5182-489C-946E-E49C7459A607Q29821933-B4B55401-4DF2-459D-95BD-CB660F8781B0Q29822662-879A74E2-E302-4D1E-84CD-ACEB041C839AQ29830733-3015F997-65CF-4559-938E-E9886D8637B0Q29830754-8C4CB5D0-0F7E-4E5D-AA7E-7FB78521FD74Q29831303-222F7BE7-B77C-413A-AEF0-CFF8E9674018Q29834710-C079726B-D627-4F7C-AFA6-F16F37C75D40
P682
description
Any process that modulates the diameter of blood vessels.
@en
biologisch proces
@nl
einkvan prosess som modulerer diameteren til ei blodåre
@nn
name
regulation of blood vessel diameter
@en
regulering av blodårediameter
@nn
type
label
regulation of blood vessel diameter
@en
regulering av blodårediameter
@nn
altLabel
GO:0097746
@en
prefLabel
regulation of blood vessel diameter
@en
regulering av blodårediameter
@nn
P2888
P686
GO:0097746